Collaborations: Research & Development

ORYZON leverages its relationships with the broader research community to advance its epigenetic scientific platform and product development strategy. These research collaborations are important contributors to the company’s product pipeline growth, and continue to provide expertise for the company in a cost effective manner.

ORYZON’s business development strategy is guided in general by moving its product development through clinical Phase II, and then forging mutually advantageous collaborations with partners who can provide later stage clinical development, regulatory and commercialization expertise and financial resources. 

The company anticipates continuing to develop both its R&D collaborations and its business development collaborations to drive the growth of its business.